Meeder Asset Management Inc Cara Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $49 - $75	6 Added 17.65%	40 $0
Q2 2022 Aug 08, 2022	SELL	$7.45 - $13.84 $16,896 - $31,389	-2,268 Reduced 98.52%	34 $0
Q1 2022 May 10, 2022	BUY	$9.94 - $12.65 $22,881 - $29,120	2,302 New	2,302 $28,000
Q4 2021 Feb 11, 2022	SELL	$11.99 - $18.14 $35 - $54	-3 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$11.55 - $16.06 $34 - $48	3 New	3 $0
Q2 2020 Aug 11, 2020	SELL	$12.39 - $17.33 $8,177 - $11,437	-660 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.12 - $17.78 $6,019 - $11,734	660 New	660 $9,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.